Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Counsyl | RCV000673251 | SCV000798433 | likely pathogenic | Hurler syndrome | 2018-03-05 | criteria provided, single submitter | clinical testing | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323676 | SCV004030091 | likely pathogenic | Mucopolysaccharidosis type 1 | 2023-07-28 | criteria provided, single submitter | clinical testing | Variant summary: IDUA c.3G>A (p.Met1Ile) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon (M133). Two of three in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 106268 control chromosomes. c.3G>A has been reported in the literature in compound heterozygosity with a nonsense variant (Tyr343*) in one individual affected with Mucopolysaccharidosis Type 1 (Lee-Chen_1997). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Other variants upstream of the nearest downstream initiation codon (M133) have been classified as pathogenic by our laboratory. The following publication has been ascertained in the context of this evaluation (PMID: 9391892). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. |